Citation: Pk. Morrish et al., MEASURING THE RATE OF PROGRESSION AND ESTIMATING THE PRECLINICAL PERIOD OF PARKINSONS-DISEASE WITH [F-18] DOPA PET, Journal of Neurology, Neurosurgery and Psychiatry, 64(3), 1998, pp. 314-319
Citation: Pk. Morrish et al., CAN THE NEUROPROTECTIVE EFFICACY OF AN AGENT EVER BE CONCLUSIVELY PROVEN, European journal of neurology, 4, 1997, pp. 19-24
Authors:
PICCINI P
MORRISH PK
TURJANSKI N
SAWLE GV
BURN DJ
WEEKS RA
MARK MH
MARAGANORE DM
LEES AJ
BROOKS DJ
Citation: P. Piccini et al., DOPAMINERGIC FUNCTION IN FAMILIAL PARKINSONS-DISEASE - A CLINICAL ANDF-18 DOPA POSITRON EMISSION TOMOGRAPHY STUDY, Annals of neurology, 41(2), 1997, pp. 222-229
Authors:
CEBALLOSBAUMANN AO
JENKINS IH
MORRISH PK
BROOKS DJ
REHNCRONA S
ODIN P
WIDNER H
BRUNDIN P
BJORKLUND A
LINDVALL O
Citation: Ao. Ceballosbaumann et al., INCREASE OF MOVEMENT-RELATED ACTIVATION OF THE SUPPLEMENTARY MOTOR AREA AFTER EMBRYONIC MESENCEPHALIC GRAFTING IN PARKINSONS-DISEASE, Neurology, 46(2), 1996, pp. 6101-6101
Authors:
MORRISH PK
SAWLE GV
BROOKS DJ
WENNING GK
QUINN NP
MARSDEN CD
REHNCRONA S
BRUNDIN P
ODIN P
WIDNER W
GUSTAVII B
BJORKLUND A
LINDVALL O
Citation: Pk. Morrish et al., LONG-TERM FOLLOW-UP, BY F-18 DOPA PET, OF IPSILATERAL AND CONTRALATERAL STRIATAL FUNCTION AFTER UNILATERAL EMBRYONIC MESENCEPHALIC IMPLANTATION IN PARKINSONS-DISEASE, Neurology, 46(2), 1996, pp. 58001-58001
Authors:
WENNING GK
MORRISH PK
SAWLE GV
QUINN NP
MARSDEN CD
BROOKS AJ
REHNCRONA S
BRUNDIN P
ODIN P
WIDNER H
GUSTAVII B
BJORKLUND A
LINDVALL O
Citation: Gk. Wenning et al., BILATERAL EMBRYONIC MESENCEPHALIC DRAFTS IN PATIENTS WITH PARKINSONS-DISEASE - INTERIM ANALYSIS OF LONG-TERM FOLLOW-UP AFTER UNILATERAL CRAFTING, Neurology, 46(2), 1996, pp. 58002-58002
Citation: Pk. Morrish et al., CLINICAL AND [F-18] DOPA PET FINDINGS IN EARLY PARKINSONS-DISEASE, Journal of Neurology, Neurosurgery and Psychiatry, 59(6), 1995, pp. 597-600
Authors:
SAWLE GV
BURN DJ
MORRISH PK
LAMMERTSMA AA
SNOW BJ
LUTHRA S
OSMAN S
BROOKS DJ
Citation: Gv. Sawle et al., THE EFFECT OF ENTACAPONE (OR-611) ON BRAIN [F-18] 6-L-FLUORODOPA METABOLISM - IMPLICATIONS FOR LEVODOPA THERAPY OF PARKINSONS-DISEASE, Neurology, 44(7), 1994, pp. 1292-1297